Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Cited by (1,001)

Items 401–500 of 1,001

  1. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains
    Hal P. Bogerd, Heather L. Wiegand, Brian Doehle, Bryan R. Cullen · 2007 · Virology
  2. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
    Yeshitila N. Friew, Vitaly P. Boyko, Wei-Shau Hu, Vinay K. Pathak · 2009 · Retrovirology
  3. Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+T Cells
    Dimitrios N. Vatakis, Gregory C. Bristol, Thomas A. Wilkinson, S A Chow, Jerome A. Zack · 2007 · Journal of Virology
  4. The Innate Antiretroviral Factor APOBEC3G Does Not Affect Human LINE-1 Retrotransposition in a Cell Culture Assay
    Priscilla Turelli, Sandrine Vianin, Didier Trono · 2004 · Journal of Biological Chemistry
  5. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair
    Roni Nowarski, Ofer I. Wilner, Ori Cheshin, Or David Shahar, Edan Kenig, Leah Baraz, Elena Britan‐Rosich, Arnon Nagler, Reuben S. Harris, Michal Goldberg et al. · 2012 · Blood
  6. LINE-1 Retrotransposable Element DNA Accumulates in HIV-1-Infected Cells
    Richard Brad Jones, Haihan Song, Yang Xu, Keith E. Garrison, Anton A. Buzdin, Naveed Muhammad Anwar, Diana V. Hunter, Shariq Mujib, Vesna Mihajlovic, Eric Martin et al. · 2013 · Journal of Virology
  7. APOBEC: From mutator to editor
    Bei Yang, Xiaosa Li, Liqun Lei, Jia Chen · 2017 · Journal of genetics and genomics/Journal of Genetics and Genomics
  8. APOBEC3F and APOBEC3G mRNA Levels Do Not Correlate with Human Immunodeficiency Virus Type 1 Plasma Viremia or CD4 + T-Cell Count
    Soo‐Jin Cho, Henning Drechsler, Ryan C. Burke, Max Q. Arens, William G. Powderly, Nicholas O. Davidson · 2006 · Journal of Virology
  9. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance
    Carole Bampi, S. Jacquenet, Daniela Lener, Didier Décimo, Jean‐Luc Darlix · 2004 · The International Journal of Biochemistry & Cell Biology
  10. Mutagenesis-Induced, Large Fitness Variations with an Invariant Arenavirus Consensus Genomic Nucleotide Sequence
    Ana Grande-Pérez, Gema Gómez‐Mariano, Pedro Ricardo Lowenstein, Esteban Domingo · 2005 · Journal of Virology
  11. Dual effect of APOBEC3G on Hepatitis B virus
    Chiemi Noguchi, Nobuhiko Hiraga, Nami Mori, Masataka Tsuge, Michio Imamura, Shoichi Takahashi, Yoshifumi Fujimoto, Hidenori Ochi, Hiromi Abe, Toshiro MAEKAWA et al. · 2007 · Journal of General Virology
  12. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles
    Barbara Guarino, Markus Rimann, Martin Fussenegger · 2005 · Metabolic Engineering
  13. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses
    Yong He, Jiahui Zhou, Huizhan Gao, Chuanfeng Liu, Peng Zhan, Xinyong Liu · 2023 · European Journal of Medicinal Chemistry
  14. Stimulation of Cell Surface CCR5 and CD40 Molecules by Their Ligands or by HSP70 Up-Regulates APOBEC3G Expression in CD4+ T Cells and Dendritic Cells
    Jeffrey Pido-Lopez, Trevor Whittall, Yufei Wang, Lesley A. Bergmeier, Kaboutar Babaahmady, Mahavir Singh, Thomas Lehner · 2007 · The Journal of Immunology
  15. APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations
    Ben Berkhout, Anthony de Ronde · 2004 · AIDS
  16. Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion
    Nicole Grandi, Marta Cadeddu, Maria Paola Pisano, Francesca Esposito, Jonas Blomberg, Enzo Tramontano · 2017 · Mobile DNA
  17. The DNA repair genes XPB and XPD defend cells from retroviral infection
    Kristine E. Yoder, Alain R. Sarasin, Kenneth H. Kraemer, Michael A. McIlhatton, Frederic D. Bushman, Richard A. Fishel · 2006 · Proceedings of the National Academy of Sciences
  18. Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K–Related Sequences
    Contreras-Galindo, Rafael, Kaplan, Mark H., Dube, Derek, Gonzalez-Hernandez, Marta J., Chan, Susana, Meng, Fan, Dai, Manhong, Omenn, Gilbert S., Gitlin, Scott D., Markovitz, David M. · 2015 · Journal of Virology
  19. Double-Stranded RNA Adenosine Deaminase ADAR-1-Induced Hypermutated Genomes among Inactivated Seasonal Influenza and Live Attenuated Measles Virus Vaccines
    Rodolphe Suspène, Vincent Petit, David Zemmour, Marie-Ming Aynaud, Michel Henry, Denise Guétard, Christophe Rusniok, Simon Wain–Hobson, Jean‐Pierre Vartanian · 2010 · Journal of Virology
  20. Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G
    David J. Stanley, Koen Bartholomeeusen, David C. Crosby, Dong Young Kim, Eunju Kwon, Linda Yen, Nathalie Caretta Cartozo, Ming Li, Stefanie Jäger, Jeremy Mason-Herr et al. · 2012 · PLoS Pathogens
  21. Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA
    Atanu Maiti, Wazo Myint, Tapan Kanai, Krista A. Delviks‐Frankenberry, Christina Sierra Rodriguez, Vinay K. Pathak, Celia A. Schiffer, Hiroshi Matsuo · 2018 · Nature Communications
  22. The viral infectivity factor (Vif) of HIV-1 unveiled
    Kristine M. Rose, Mariana Marin, Susan L. Kozak, David Kabat · 2004 · Trends in Molecular Medicine
  23. 5′ to 3′ mRNA Decay Factors Colocalize with Ty1 Gag and Human APOBEC3G and Promote Ty1 Retrotransposition
    James A. Dutko, Alison E. Kenny, Eric Gamache, M. Joan Curcio · 2010 · Journal of Virology
  24. M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication
    Luca Cassetta, Anna Kajaste‐Rudnitski, Tiziana Coradin, Elisa Saba, Giulia Della Chiara, Marialuisa Barbagallo, Francesca Graziano, Massimo Alfano, Edana Cassol, Elisa Vicenzi et al. · 2013 · AIDS
  25. Cooperative and Specific Binding of Vif to the 5′ Region of HIV-1 Genomic RNA
    Simon Henriet, Delphine Richer, Serena Bernacchi, Étienne Decroly, Robert Vigne, Bernard Ehresmann, Chantal Ehresmann, Jean‐Christophe Paillart, Roland Marquet · 2005 · Journal of Molecular Biology
  26. Interaction with 7SL RNA but Not with HIV-1 Genomic RNA or P Bodies Is Required for APOBEC3F Virion Packaging
    Tao Wang, Chunjuan Tian, Wenyan Zhang, Phuong Thi Nguyen Sarkis, Xiao-Fang Yu · 2007 · Journal of Molecular Biology
  27. Protocol for Nearly Full-Length Sequencing of HIV-1 RNA from Plasma
    Yuka Nadai, Lindsay M. Eyzaguirre, Niel T. Constantine, Anne McDonnell Sill, Farley R. Cleghorn, William A. Blattner, Jean K. Carr · 2008 · PLoS ONE
  28. Recent insights into HIV-1 Vif
    Francisco Navarro, Nathaniel Roy Landau · 2004 · Current Opinion in Immunology
  29. Single-stranded DNA Scanning and Deamination by APOBEC3G Cytidine Deaminase at Single Molecule Resolution
    Gayan Senavirathne, Malgorzata M. Jaszczur, Paul A. Auerbach, Thomas G. Upton, Linda Chelico, Myron F. Goodman, David Rueda · 2012 · Journal of Biological Chemistry
  30. Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins
    Wenyan Zhang, Gongying Chen, Anna Maria Niewiadomska, Rongzhen Xu, Xiao-Fang Yu · 2008 · PLoS ONE
  31. The current structural and functional understanding of APOBEC deaminases
    Ronda Bransteitter, Courtney Prochnow, Xiaojiang S. Chen · 2009 · Cellular and Molecular Life Sciences
  32. Lethal mutagenesis of HIV
    Robert A. Smith, Lawrence A. Loeb, Bradley D. Preston · 2005 · Virus Research
  33. Mucosal immune responses in the genital tract of HIV‐1‐exposed uninfected women
    Taha Hirbod, Kristina Broliden · 2007 · Journal of Internal Medicine
  34. Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells
    Kholiswa C. Ngumbela, Kieran P. Ryan, Rohini Sivamurthy, Mark A. Brockman, Rajesh Tim Gandhi, Nina Bhardwaj, Daniel G. Kavanagh · 2008 · PLoS ONE
  35. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions
    Kimberly M. Prohaska, Ryan P. Bennett, Jason D. Salter, Harold C. Smith · 2014 · Wiley Interdisciplinary Reviews - RNA
  36. Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators
    Hal P. Bogerd, Anand V. R. Kornepati, Joy B. Marshall, Edward M. Kennedy, Bryan R. Cullen · 2015 · Proceedings of the National Academy of Sciences
  37. Functional Analysis and Structural Modeling of Human APOBEC3G Reveal the Role of Evolutionarily Conserved Elements in the Inhibition of Human Immunodeficiency Virus Type 1 Infection and Alu Transposition
    Yannick Bulliard, Priscilla Turelli, Ute F. Röhrig, Vincent Zoete, Bastien Mangeat, Olivier Alain Michielin, Didier Trono · 2009 · Journal of Virology
  38. Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches
    Mariana Santa‐Marta, Paula Matos de Brito, Ana Godinho‐Santos, João Gonçalves · 2013 · Frontiers in Immunology
  39. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma
    Yang Deng, Yan Du, Qi Zhang, Xue Na Han, Guangwen Cao · 2013 · Cancer Letters
  40. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity
    In‐Ja L. Byeon, Chang‐Hyeock Byeon, Tiyun Wu, Mithun Mitra, Dustin Singer, Judith G. Levin, Angela M. Gronenborn · 2016 · Biochemistry
  41. RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease
    Taga Lerner, Fotini Nina Papavasiliou, Riccardo Pecori · 2018 · Genes
  42. Murine T Cells Potently Restrict Human Immunodeficiency Virus Infection
    Jörg G. Baumann, Derya Unutmaz, Michael D. Miller, Sabine K. J. Breun, Stacy M. Grill, Jane Mirro, Dan R. Littman, Alan R. Rein, Vineet N. KewalRamani · 2004 · Journal of Virology
  43. Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them between Cytoplasmic Sites of mRNA Metabolism
    Mariana Marin, Sheetal Golem, Kristine M. Rose, Susan L. Kozak, David Kabat · 2007 · Journal of Virology
  44. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins
    Hendrik Huthoff, Michael H. Malim · 2005 · Virology
  45. Dendritic cell based vaccines for HIV infection
    Felipe García, Montserrat Plana, Núria Climent, Agathe León, José M. Gatell, Teresa Gallart · 2013 · Human Vaccines & Immunotherapeutics
  46. Structure-Guided Analysis of the Human APOBEC3-HIV Restrictome
    Halil Aydin, Matthew W. Taylor, Jeffrey E. Lee · 2014 · Structure
  47. Intensity of Deoxycytidine Deamination of HIV-1 Proviral DNA by the Retroviral Restriction Factor APOBEC3G Is Mediated by the Noncatalytic Domain
    Yuqing Feng, Linda Chelico · 2011 · Journal of Biological Chemistry
  48. APOBEC3 Proteins Expressed in Mammary Epithelial Cells Are Packaged into Retroviruses and Can Restrict Transmission of Milk-Borne Virions
    Chioma M. Okeoma, Alyssa Huegel, Jaisri R. Lingappa, Michael D. Feldman, Susan R. Ross · 2010 · Cell Host & Microbe
  49. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G
    James H Miller, Vladimir Presnyak, Harold C. Smith · 2007 · Retrovirology
  50. Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
    Michael C. Letko, Thijs Booiman, Neeltje A. Kootstra, Viviana R. Simon, Marcel Ooms · 2015 · Cell Reports
  51. The Opening of Pandora's Box: An Emerging Role of Long Noncoding RNA in Viral Infections
    Pin Wang · 2019 · Frontiers in Immunology
  52. Regulated Production and Anti-HIV Type 1 Activities of Cytidine Deaminases APOBEC3B, 3F, and 3G
    Kristine M. Rose, Mariana Marin, Susan L. Kozak, David Kabat · 2005 · AIDS Research and Human Retroviruses
  53. Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+T Cells
    Gabriela Plesa, Jihong Dai, Clifford Baytop, James L. Riley, Carl H. June, Una O’Doherty · 2007 · Journal of Virology
  54. APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure
    Colleen M. Holtz, Holly A. Sadler, Louis M. Mansky · 2013 · Nucleic Acids Research
  55. Mutations in HIV-1 Reverse Transcriptase Affect the Errors Made in a Single Cycle of Viral Replication
    Michael E. Abram, Andrea L. Ferris, Kalyan Das, Octavio A. Quiñones, Wei Shao, Steven J. Tuske, W. Gregory Alvord, Eddy Arnold, Stephen H. Hughes · 2014 · Journal of Virology
  56. Structural Insights into HIV-1 Vif-APOBEC3F Interaction
    Masaaki Nakashima, Hirotaka Ode, Takashi Kawamura, Shingo Kitamura, Yuriko Naganawa, Hiroaki Awazu, Shinya Tsuzuki, Kazuhiro Matsuoka, Michiko Nemoto, Atsuko Hachiya et al. · 2015 · Journal of Virology
  57. APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms
    Ayaka Okada, Yasumasa Iwatani · 2016 · Frontiers in Microbiology
  58. Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions
    Tania V. Silvas, Shurong Hou, Wazo Myint, E.A. Nalivaika, Mohan Somasundaran, Brian A. Kelch, Hiroshi Matsuo, Neşe Kurt Yılmaz, Celia A. Schiffer · 2018 · Scientific Reports
  59. Ubiquitination of APOBEC3 proteins by the Vif–Cullin5–ElonginB–ElonginC complex
    Kotaro Shirakawa, Akifumi Takaori‐Kondo, Masayuki Kobayashi, Mitsunori Tomonaga, Taisuke Izumi, Keiko Fukunaga, Amane Sasada, Aierken Abudu, Yasuhiro Miyauchi, Hirofumi Akari et al. · 2005 · Virology
  60. Differential Anti-APOBEC3G Activity of HIV-1 Vif Proteins Derived from Different Subtypes
    Yukie Iwabu, Masanobu Kinomoto, Masashi Tatsumi, Hideaki Fujita, Mari Shimura, Yoshitaka Tanaka, Yukihito Ishizaka, David A Nolan, Simon Alexander Mallal, Tetsutaro Sata et al. · 2010 · Journal of Biological Chemistry
  61. Characterization of a Novel Cullin5 Binding Domain in HIV-1 Vif
    Zuoxiang Xiao, Yong Xiong, Wenyan Zhang, Lindi Tan, Elana S. Ehrlich, Deyin Guo, Xiao-Fang Yu · 2007 · Journal of Molecular Biology
  62. HIV Pathogenesis: Knowledge Gained after Two Decades of Research
    Jay A. Levy · 2006 · Advances in Dental Research
  63. Low Accumulation of L90M in Protease from Subtype F HIV‐1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism
    Alexandre Calazans, Rodrigo Brindeiro, Patrícia A. Brindeiro, Hugo Verli, Monica Barcelos Arruda, Luis M. F. Gonzalez, Jorge A. Guimarães, Ricardo Sobhie Diaz, Octávio Augusto Ceva Antunes, Amílcar Tanuri · 2005 · The Journal of Infectious Diseases
  64. APOBEC3G: an intracellular centurion
    Ya‐Lin Chiu, Warner C. Greene · 2008 · Philosophical Transactions of the Royal Society B Biological Sciences
  65. Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos
    Christelle Etard, Urmas Roostalu, Uwe Strähle · 2010 · The Journal of Cell Biology
  66. The RNA Binding Specificity of Human APOBEC3 Proteins Resembles That of HIV-1 Nucleocapsid
    Ashley York, Sebla B. Kutluay, Manel Errando, Paul D. Bieniasz · 2016 · PLoS Pathogens
  67. Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis
    Shunsuke Okuyama, Hiroyuki Marusawa, Tomonori Matsumoto, Yoshihide Ueda, Yuko Mizuno Matsumoto, Yoko Endo, Atsushi Takai, Tsutomu Chiba · 2011 · International Journal of Cancer
  68. Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
    Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Luis Menéndez‐Arias · 2022 · Viruses
  69. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation
    María-Soledad Valera, Laura de Armas‐Rillo, Jonathan Barroso González, Serena Ziglio, Julien Batisse, Noé Dubois, Sara Marrero‐Hernández, Sophie Borel, Laura García-Expósito, Martine Biard‐Piechaczyk et al. · 2015 · Retrovirology
  70. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses
    Markus Fehrholz, Sabine Kendl, Christiane Prifert, Benedikt Weißbrich, Ken Lemon, Linda J. Rennick, William Paul Duprex, BERT K. RIMA, Fransje A. Koning, Rebecca K. Holmes et al. · 2011 · Journal of General Virology
  71. Intercompartmental Recombination of HIV-1 Contributes toenvIntrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors
    Richard J. P. Brown, Paul J. Peters, Catherine Caron, Maria Paz Gonzalez-Perez, Leanne Stones, Chiambah Ankghuambom, Kemebradikumo Pondei, C. Patrick McClure, George A. Alemnji, Stephen R. Taylor et al. · 2011 · Journal of Virology
  72. The Breadth of Antiviral Activity of Apobec3DE in Chimpanzees Has Been Driven by Positive Selection
    Nisha K. Duggal, Harmit Singh Malik, Michael Emerman · 2011 · Journal of Virology
  73. Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals
    Ping An, Priya Duggal, Li Hua Wang, Stephen J. O’Brien, Sharyne M Donfield, James J. Goedert, John Phair, Susan Buchbinder, Gregory Dale Kirk, Cheryl Ann Winkler · 2007 · PLoS Genetics
  74. DNA deamination in immunity
    Svend K. Petersen‐Mahrt · 2005 · Immunological Reviews
  75. Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression
    Jennifer B. Nietupski, Gregory D Hurlbut, Robin J. Ziegler, Qiuming Chu, Bradley L. Hodges, Karen M. Ashe, Mark P. Bree, Seng H. Cheng, Richard J. Gregory, John Marshall et al. · 2011 · Molecular Therapy
  76. HIV Restriction by APOBEC3 in Humanized Mice
    John F. Krisko, Francisco J. Martinez-Torres, John L. Foster, J. Víctor García · 2013 · PLoS Pathogens
  77. APOBEC3s: DNA‐editing human cytidine deaminases
    Tania V. Silvas, Celia A. Schiffer · 2019 · Protein Science
  78. HIV-1 assembly and maturation
    A. G. Bukrinskaya · 2004 · Archives of Virology
  79. Interactions of HIV and Drugs of Abuse
    Kurt F. Hauser, Pamela E. Knapp · 2014 · International review of neurobiology
  80. Host–virus interaction and viral evasion
    Scheilla Teixeira Strumillo, Denis Kartavykh, Fábio Ferreira de Carvalho, Nicolly Cruz, Ana Caroline de Souza Teodoro, Ricardo Sobhie Diaz, Marli F. Curcio · 2021 · Cell Biology International
  81. Roles of Gag and NCp7 in Facilitating \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathbf{tRNA}_{3}^{\mathbf{Lys}}\) \end{document} Annealing to Viral RNA in Human Immunodeficiency Virus Type 1
    Guo, Fei, Saadatmand, Jenan, Niu, Meijuan, Kleiman, Lawrence · 2009 · Journal of Virology
  82. Learning from the Messengers: Innate Sensing of Viruses and Cytokine Regulation of Immunity — Clues for Treatments and Vaccines
    Jesper Melchjorsen · 2013 · Viruses
  83. Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo
    Spyridon Stavrou, Daniel Crawford, Kristin Blouch, Edward P. Browne, Rahul M. Kohli, Susan R. Ross · 2014 · PLoS Pathogens
  84. The Restriction of Zoonotic PERV Transmission by Human APOBEC3G
    S. Jönsson, Rebecca S. LaRue, Mark D. Stenglein, Scott C. Fahrenkrug, Valgerður Andrésdóttir, Reuben S. Harris · 2007 · PLoS ONE
  85. APOBEC3 proteins and reverse transcription
    Renato Santana Aguiar, Boris Matija Peterlin · 2008 · Virus Research
  86. HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis
    Kenneth C. Williams, Tricia H. Burdo · 2009 · Apmis
  87. Biochemical Differentiation of APOBEC3F and APOBEC3G Proteins Associated with HIV-1 Life Cycle
    Xiaojun Wang, Patrick Dolan, Ying Dang, Yong‐Hui Zheng · 2006 · Journal of Biological Chemistry
  88. Target Cell APOBEC3C Can Induce Limited G-to-A Mutation in HIV-1
    Khaoula Bourara, Teri J. Liegler, Robert M. Grant · 2007 · PLoS Pathogens
  89. A DNA Sequence Recognition Loop on APOBEC3A Controls Substrate Specificity
    Eric C. Logue, Nicolin Bloch, Erica Dhuey, Ruonan Zhang, Ping Cao, Cécile Hérate, Lise Chauveau, Stevan R. Hubbard, Nathaniel Roy Landau · 2014 · PLoS ONE
  90. Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF–ElonginC interaction inhibitors
    Wenlin Huang, Tao Zuo, Hongwei Jin, Zhenming Liu, Zhenjun Yang, Xianghui Yu, Liangren Zhang, Lihe Zhang · 2013 · Molecular Diversity
  91. Composition bias and genome polarity of RNA viruses
    Prasert Auewarakul · 2004 · Virus Research
  92. APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians
    Han Sang Valcke, Nicole Flore Bernard, Julie Bruneau, Michel Alary, Christos Micheal Tsoukas, Michel Roger · 2006 · AIDS
  93. Sequence Variability, Gene Structure, and Expression of Full-Length Human Endogenous Retrovirus H
    Patric Jern, Göran Sperber, Göran Ahlsén, Jonas Blomberg · 2005 · Journal of Virology
  94. Induction of APOBEC3 In Vivo Causes Increased Restriction of Retrovirus Infection
    Chioma M. Okeoma, Audrey Low, Will Bailis, Hung Fan, Boris Matija Peterlin, Susan R. Ross · 2009 · Journal of Virology
  95. HERV ‐K( HML ‐2), a seemingly silent subtenant – but still waters run deep
    Kirsten Hanke, Oliver Höhn, Norbert Bannert · 2016 · Apmis
  96. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.
    Guylaine Haché, Louis M. Mansky, Reuben S. Harris · 2006 · PubMed
  97. Molecular mechanisms of FIV infection
    John H. Elder, Magnus Sundström, Sohela de Rozìeres, Aymeric de Parseval, Chris K. Grant, Ying‐Chuan Lin · 2008 · Veterinary Immunology and Immunopathology
  98. Nuclear Exclusion of the HIV-1 Host Defense Factor APOBEC3G Requires a Novel Cytoplasmic Retention Signal and Is Not Dependent on RNA Binding
    Ryan P. Bennett, Vladimir Presnyak, Joseph E. Wedekind, Harold C. Smith · 2007 · Journal of Biological Chemistry
  99. SAMHD1 Host Restriction Factor: A Link with Innate Immune Sensing of Retrovirus Infection
    Alexandre Sze, David P. Olagnier, Rongtuan Lin, Julien van Grevenynghe, John B. Hiscott · 2013 · Journal of Molecular Biology
  100. Uracil within DNA: an actor of antiviral immunity
    Joséphine Sire, Gilles Quérat, Cécile Esnault, Stéphane Priet · 2008 · Retrovirology